Sanara MedTech Inc. (SMTI)
NASDAQ: SMTIHealthcareMedical Instruments & SuppliesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
SMTI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $322.04M
- Forward P/E
- 64.91
- EPS (TTM)
- -$0.04
- Dividend yield
- None
- 52-week range
- 16.05 – 35.34
- Day range
- 34.97 – 35.11
- Volume / Avg
- 136.15K / 276.85K
- Beta
- —
- Shares outstanding
- 9.19M
- Next earnings
- Nov 11, 2026
52-week range
SMTI stock today
On Oct 7, SMTI ended the session at $35.05, adding $0.05 (0.14%), versus the S&P 500's 0.22% decline. Trading was light, with 136.15K shares changing hands, about 49% of the average daily volume. Shares are 0.8% below their 52-week high of $35.34, set on Sep 22, 2026 and 118.4% above the 52-week low of $16.05, near the top of the past year's range.
SMTI is up 50.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 15.6%. Sanara MedTech has posted a net loss over the last twelve months (EPS of -$0.04), so its P/E ratio is not meaningful. Sanara MedTech's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Sanara MedTech
Company profileSanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Mr. Seth D. Yon
- Headquarters
- Fort Worth, TX
- Employees
- 108
- Website
- sanaramedtech.com
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$35.00-0.14%
- Strong buy 0
- Buy 0
- Hold 3
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 11, 2026
Sanara MedTech peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EMBCEmbecta Corp. | 5.91 | -0.67% | $334.86M | vs SMTI |
| OSUROraSure Technologies Inc. | 3.73 | -1.06% | $257.25M | vs SMTI |
| UTMDUtah Medical Products Inc. | 73.45 | -0.51% | $233.12M | vs SMTI |
| NNNNAnbio Biotechnology Class A | 4.90 | 0.00% | $215.07M | vs SMTI |
| PDEXPro-Dex Inc. | 62.80 | -3.27% | $201.17M | vs SMTI |
| ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A | 2.12 | +6.53% | $158.29M | vs SMTI |
| KRMDKORU Medical Systems Inc. | 2.98 | -0.67% | $136.88M | vs SMTI |
| ANGOAngioDynamics Inc. | 14.19 | -1.59% | $596.75M | vs SMTI |
Indexes, lists and sector
Appears in lists
Sanara MedTech stock FAQ
What is Sanara MedTech's stock price today?
SMTI last traded at $35.05 as of Oct 7, 4:00 PM EDT, up 0.14% on the day. Prices are delayed at least 15 minutes.
Does Sanara MedTech pay a dividend?
No. Sanara MedTech does not currently pay a regular cash dividend.
When is Sanara MedTech's next earnings date?
Sanara MedTech is expected to report earnings on Wednesday, November 11, 2026.
Who is Sanara MedTech's CEO?
Mr. Seth D. Yon is the chief executive officer of Sanara MedTech Inc., which has about 108 employees.
Has SMTI ever split its stock?
Yes. The most recent SMTI stock split was a 1-for-100 split on May 10, 2019, one of 2 splits on record.
What is the SMTI 52-week high?
The 52-week high for SMTI is $35.34 and the 52-week low is $16.05. The stock is currently 0.8% below its high.